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Abstract
CONTRAST, a new gene-prediction algorithm that uses sophisticated machine-learning techniques,
has pushed de novo prediction accuracy to new heights, and has significantly closed the gap
between de novo and evidence-based methods for human genome annotation.
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Gene prediction is one of the most important and alluring
problems in computational biology. Its importance comes
from the inherent value of the set of protein-coding genes for
other analysis. Its allure is based on the apparently simple
rules that the transcriptional machinery uses: strong, easily
recognizable signals within the genome such as open reading
frames, consensus splice sites and nearly universal start and
stop codon sequences. These signals are highly conserved,
are relatively easy to model, and have been the focus of a
number of algorithms trying to locate all the protein-coding
genes in a genome using only the sequence of one or more
genomes. This technique, so-called de novo prediction, does
not use information about expressed sequences such as
proteins or mRNAs.
In this month’s issue of Genome Biology, Gross and colleagues
[1] describe the gene-prediction program CONTRAST, the
latest significant advance in de novo gene prediction. The
program exploits patterns inherent in multiple sequence
alignments while making few assumptions about evolution-
ary processes. Its accuracy is considerably higher than any
other  de novo prediction program and has significantly
closed the gap between de novo and evidence-based methods
for human genome annotation.
There have been two previous significant breakthroughs in
de novo human gene prediction. The first was the identi-
fication and optimization of algorithms to effectively model
the problem. The second was the use of an evolutionarily
related genome sequence to reliably increase both the
sensitivity and specificity of the predictions. Both advances
are briefly discussed below (for more on the history of gene
finding see [2]).
Algorithms based on a generalized hidden Markov model
(GHMM) framework have been particularly successful for
gene prediction. A GHMM can be used to describe the
relationship between the components of a protein-coding
gene (such as exons and splice sites) and the sequence of
genomic DNA in which the gene is found. The best-known
example of this method is the program GENSCAN [3], which
in 1997 was shown to be dramatically more accurate than the
previous state-of-the-art prediction programs. GENSCAN
was easy to use, very fast, and predicted genes in the long
sequences of genomic DNA that would characterize the
human genome project. Although subsequently shown to
predict only 10–15% of genes correctly on realistic genome-
wide datasets [4,5], GENSCAN remains a popular bio-
informatics tool. GENSCAN predictions continue to be a
standard feature for every genome released on both the
University of California Santa Cruz (UCSC) [6] and Ensembl
[7] genome browsers.
In 2002, with the publication of the mouse genome sequence
[8], human gene prediction formally entered the era of
comparative genomics (see Figure 1 for a comparison of the
programs). A number of programs were developed to exploit
this new data source. In both human-mouse comparisons
and across the tree of life, the most successful of these
dedicated algorithms was TWINSCAN [9], a gene-prediction
program that exploited the signature of evolution using a
reimplementation and extension of the GENSCAN GHMM
model. TWINSCAN’s improved accuracy featured a dramatic
reduction in false-positive predictions, while managing to
predict about 25% of human protein-coding genes com-
pletely accurately [5,10]. TWINSCAN itself was then
extended with a more expressive model of evolutionaryconservation derived from a multiple sequence alignment of
several complete genomes. This extension, known as N-
SCAN, predicts approximately 35% of human genes correctly
[5], but is no more accurate with a multiple sequence
alignment than it is with the most informative pairwise
genome alignment [10]. Thus, even though the N-SCAN
model of evolutionary conservation is better than the one
used by TWINSCAN, N-SCAN is not benefiting from the
additional genome sequences used in the alignment.
At the same time as these advances in de novo gene
prediction, evidence-based gene prediction was also progres-
sing rapidly. The best evidence-based systems integrate data
from sources such as mRNA and protein sequences to
predict specific genes that are supported by a variety of
expressed sequences [11,12]. These evidence-based gene sets
are often used for other biological analyses such as [13].
CONTRAST is a dramatic advance on the previous state of
the art [1]. Using the Consensus CDS (CCDS) [14] set as the
gold standard, CONTRAST predicts nearly 60% of the genes
correctly using only the human genome sequence and a
multiple alignment with 11 so-called ‘informant’ genome
sequences. This result is a stunning improvement on the
previous state-of-the-art de novo gene-prediction algorithms
both on the CCDS set and the gold standard manually anno-
tated genes used for the ENCODE Genome Annotation
Assessment Project (EGASP) [5] (Figure 1). Close examina-
tion of the EGASP results shows that CONTRAST compares
very favorably with even the best evidence-based, expressed
sequence prediction methods, especially for exon accuracy.
To achieve this, Gross et al. [1] did something unconventional
in the gene-prediction field. They ignored what is known
about evolutionary relationships and assumed that there
must be additional information in the multiple sequence
alignment even if they could not exactly say what sort of
information was there. Doing this required a switch from
generative models such as HMMs, which have been used by
essentially all previous de novo prediction programs, to
discriminative models such as support vector machines and
conditional random fields. A support vector machine (SVM)
is an example of the machine-learning technique called
‘supervised learning’, in which the algorithm is able to classify
new items based on rules it has discovered from a correctly
labeled training set. A conditional random field (CRF) can be
used to classify sequential data and is applicable to many of
the same problems as an HMM. CONTRAST uses both SVM
and CRF techniques for different parts of the gene-prediction
problem. The SVMs are used for coding region boundary
detection (splice sites, start and stop codons), whereas a CRF
is used to model the gene structure (that is, how all the pieces
fit together). Readers interested in more information about
these machine-learning techniques may like to start with a
recent biology-based primer on SVMs [15].
There are limits for biological understanding with these
new techniques. A process of evolution resulted in the
extant sequences that we see, and understanding this
process would be immensely valuable. Generative models
such as HMMs attempt to explicitly describe the
evolutionary process by generating the multiple sequence
alignment of an evolutionarily conserved exon. For
example, a phylogenetic HMM may use separate models of
molecular evolution for the first, second and third
positions of each codon [16]. Unlike phylogenetic HMMs,
discriminative machine-learning techniques such as those
used by Gross et al. [1] do not model the complexities of
the evolutionary process, but they are able to find the
subtle differences in the alignments associated with real
genes from other, very similar alignments in the genome.
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Figure 1
Increase in the accuracy of de novo gene prediction over time. The gene
sensitivity and specificity and the exon sensitivity and specificity on the
EGASP test set [5] are shown for several programs by year of initial
publication. Included are GENSCAN (1997), TWINSCAN (2001), N-
SCAN (2005) and CONTRAST (2007). Note the significant decrease in
false positive predictions (as measured by the rise in TWINSCAN’s exon
specificity) with the inital use of evolutionarily related genome sequences.
By comparison, the accuracy of the Ensembl evidence-based gene
predictions used in the EGASP experiment at the gene level were 71.6%
sensitivity and 67.3% specificity and 77.5% sensitivity and 82.7% specificity
at the exon level.
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CONTRASTIn the current implementation, training CONTRAST
requires the target genome to be at least reasonably well
annotated at the start. It is not yet clear how well it will
perform when annotating a genome with no high-quality
training data, although unpublished results from the
CONTRAST team demonstrate substantial accuracy with
only a few thousand training genes [17]. The situation
where no training data is available could be simulated, at
least for the case of human and mouse, by using one of the
genomes as a well-annotated training set and the other to
test predictive accuracy. As the most accurate de novo
prediction program, CONTRAST will help complete the
protein-coding gene set in well annotated genomes such as
human and mouse, and may be vital for accurate
annotation of complex genomes with informative sequence
alignments to related species, but without significant
expression data. Nevertheless, annotating a genome
without the sequence of a closely related species is likely to
remain a challenge.
CONTRAST is not the first program to apply these types of
machine-learning technique to the problem of computa-
tional gene prediction. Bernal et al. [18] recently introduced
a gene-prediction program called CRAIG, which does not
use any sequence alignments, but does use a semi-Markov
CRF. CRAIG shows notable improvement over a large selec-
tion of other non-alignment-based programs. However, it
performed less well than HMM-based multi-genome predic-
tion programs such as N-SCAN [5,18]. DeCaprio et al. [19]
developed Conrad, a comparative gene-prediction program
that also uses semi-Markov CRFs. Conrad shows striking
improvements on fungal genomes compared with other
leading prediction programs, but its current implementation
makes its application to large mammalian genomes
computationally prohibitive [19].
It is still the case that the best full-length gene predictions
are done by mapping expressed sequences to the genome
assembly. CONTRAST finds the initial and terminal exons of
a gene relatively difficult to predict and this somewhat limits
exact gene prediction. However, Gross et al. [1] show
convincingly that there is complex information in the
multiple sequence alignment of mammalian genomes and
that this information can be exploited to create far more
accurate gene predictions than those produced by the best
HMM-based algorithms. The performance of CONTRAST
suggests that the dominance of HMM-based programs in
gene-prediction might be waning. Without doubt, further
advances in machine-learning methods for large-scale
biological analysis will help us integrate and understand
complex biological data. A challenge for computational
biologists is to transform the language of SVMs and
discriminative learning techniques into biological models
that will help us understand the complex processes of
evolution that have created the extant species that we are
now so busily sequencing.
The development of CONTRAST is a welcome result to those
of us who believed that there must be additional information
that could be used for gene prediction in multiple sequence
alignments. Brent [2] recently suggested a number of
possible reasons why multiple sequence alignments had
failed to increase the accuracy of comparative gene predic-
tion. These included sequence quality, alignment methods,
and lack of splice site and exon conservation in the mammalian
lineage. It looks as though his final reason - that designers of
de novo gene prediction algorithms had not yet been clever
enough to come up with a solution - might well have been
the right one.
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